Aldo Pagano

Dr. Aldo Pagano

Depart of Experimental Medicine, University of Genoa, Italy
+1
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Trends in Genetics
Verified
Journal Article
Closed access
GIORGIO DIECIGIORGIO DIECI
GIORGIO DIECI
GFGloria Fiorino
Gloria Fiorino
MCManuele Castelnuovo
Manuele Castelnuovo
MTMartin Teichmann
Martin Teichmann
Aldo PaganoAldo Pagano
Aldo Pagano

1 February 2011 in Neurobiology of Disease
Verified
Journal Article
Closed access
SMSara Massone
Sara Massone
IVIrene Vassallo
Irene Vassallo
GFGloria Fiorino
Gloria Fiorino
MCManuele Castelnuovo
Manuele Castelnuovo
FBFederica Barbieri
Federica Barbieri
Aldo PaganoAldo Pagano
Aldo Pagano

1 January 2012 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
ECEleonora Ciarlo
Eleonora Ciarlo
SMSara Massone
Sara Massone
IPIlaria Penna
Ilaria Penna
MNMario Nizzari
Mario Nizzari
AGArianna Gigoni
Arianna Gigoni
Aldo PaganoAldo Pagano
Aldo Pagano
SUMMARY Recent studies indicated that sortilin-related receptor 1 (SORL1) is a risk gene for late-onset Alzheimer9s disease (AD), although its role in the aetiology and/or progression of this disorder is not fully understood. Here, we report the finding of a non-coding (nc) RNA (hereafter referred to as 51A) that maps in antisense configuration to intron 1 of the SORL1 gene. 51A expression drives a splicing shift of SORL1 from the synthesis of the canonical long protein variant A to an alternatively spliced protein form. This process, resulting in a decreased synthesis of SORL1 variant A, is associated with impaired processing of amyloid precursor protein (APP), leading to increased Aβ formation. Interestingly, we found that 51A is expressed in human brains, being frequently upregulated in cerebral cortices from individuals with Alzheimer9s disease. Altogether, these findings document a novel ncRNA-dependent regulatory pathway that might have relevant implications in neurodegeneration.

1 February 2012 in Gene
Verified
Journal Article
Closed access
AOAndrea Orioli
Andrea Orioli
CPChiara Pascali
Chiara Pascali
Aldo PaganoAldo Pagano
Aldo Pagano
MTMartin Teichmann
Martin Teichmann
GIORGIO DIECIGIORGIO DIECI
GIORGIO DIECI

1 July 2012 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Closed access
SMSara Massone
Sara Massone
ECEleonora Ciarlo
Eleonora Ciarlo
SVSerena Vella
Serena Vella
MNMario Nizzari
Mario Nizzari
TULLIO FLORIOTULLIO FLORIO
TULLIO FLORIO
Aldo PaganoAldo Pagano
Aldo Pagano

1 March 2013 in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Verified
Journal Article
Closed access
GIORGIO DIECIGIORGIO DIECI
GIORGIO DIECI
ACAnastasia Conti
Anastasia Conti
Aldo PaganoAldo Pagano
Aldo Pagano
DCDavide Carnevali
Davide Carnevali